Cubist Pharmaceuticals, Inc. (CBST) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
International product revenues: 16.62M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
International product revenues: 16.62M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $211.7 million versus the consensus estimate of $210.54 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
